Intelligence · Clinical Pipeline
Chinese University of Pipeline
All ClinicalTrials.gov programs at Chinese University of — phase, modality, and trial IDs.
- Programs
- 9
Quick answer
Chinese University of has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Amlodipine, Telmisartan, Amiloride Compound , Simvastatin
Chinese University of Hong Kong
Essential Hypertension
1 trial -
Baricitinib 4 MG
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial -
Finerenone
Chinese University of Hong Kong
Patients With Type 2 Diabetes
1 trial -
Pegyinterferon-alfa-2a
Chinese University of Hong Kong
Chronic Hepaititis B
1 trial -
Sodium valproate
Chinese University of Hong Kong
Epilepsy
1 trial -
film dressing by adhesive
Chinese University of Hong Kong
Chronic Peritoneal Dialysis
1 trial -
inactivated EV71 vaccine (KMB-17 cells)
Chinese University of Hong Kong
Hand, Foot and Mouth Disease (HFMD)
1 trial -
lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group
Chinese University of Hong Kong
Shock, Septic
1 trial -
tacrolimus
Chinese University of Hong Kong
Lupus Nephritis
1 trial
Frequently asked questions
How many pipeline programs does Chinese University of have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs